- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06363422
The Value of Epicanthoplasty on the Modification of Upper-eyelid Appearance
April 9, 2024 updated by: Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
The Value of Epicanthoplasty on the Modification of Upper-eyelid Appearance: a Retrospective Study
In East Asian populations, the combination of an epicanthic fold and mono-eyelid is one of their anatomical characteristics.
Misalignment of the orbicularis oculi muscle and fibrous connections leads to longitudinal tension, forming the epicanthic fold.
The epicanthic fold may diminish the aesthetic effects of eyelid cosmetic surgery, shorten the horizontal length, and affect the postoperative shape of double eyelids.
As upper eyelid cosmetic surgery is one of the most common cosmetic procedures in Asia, there is increasing attention on the modification of the epicanthic fold and its impact on the formation of double eyelids.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Observational
Enrollment (Actual)
14
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Shanghai, China
- Shanghai Ninth People's Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Sampling Method
Non-Probability Sample
Study Population
In East Asian populations, the combination of an epicanthic fold and mono-eyelid is one of their anatomical characteristic.
The epicanthic fold may diminish the aesthetic effects of eyelid cosmetic surgery, shorten the horizontal length, and affect the postoperative shape of double eyelids
Description
Inclusion Criteria:
1: Patients who have previously undergone unsatisfactory blepharoplasty, combined with epicanthic fold issues;
2: Underwent epicanthoplasty in this center
3: over 18-year-old and less than 60-year-old
4: Clinical data was comprehensive.
Exclusion Criteria:
- 1: The patient has concurrent untreated lacrimal defects, excessive eyelid skin, and other complications such as entropion and ectropion.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Surgical
|
Patients with unsatisfied blepharoplasty underwent epicanthoplasty in our center
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
inter-epicanthal distance (IED)
Time Frame: preoperatively and through study completion, an average of 1 year
|
The inter epicanthal distance was measured by the distance from left to right epicanthus.
|
preoperatively and through study completion, an average of 1 year
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Study Director: Lin Lu, PhD., Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 1, 2024
Primary Completion (Actual)
March 15, 2024
Study Completion (Actual)
April 1, 2024
Study Registration Dates
First Submitted
April 7, 2024
First Submitted That Met QC Criteria
April 9, 2024
First Posted (Actual)
April 12, 2024
Study Record Updates
Last Update Posted (Actual)
April 12, 2024
Last Update Submitted That Met QC Criteria
April 9, 2024
Last Verified
April 1, 2024
More Information
Terms related to this study
Other Study ID Numbers
- JY2024-012
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Patient Satisfaction
-
Shaukat Khanum Memorial Cancer Hospital & Research...CompletedSatisfaction, Patient | SatisfactionPakistan
-
Duke UniversityCompletedPatient Satisfaction | Clinician SatisfactionUnited States
-
Universitair Ziekenhuis BrusselWithdrawnPatient Satisfaction | Patient PreferenceBelgium
-
Cedars-Sinai Medical CenterTerminated
-
HaEmek Medical Center, IsraelUnknownPatient Satisfaction | Patient Compliance
-
Methodist Health SystemCompletedSatisfaction, PatientUnited States
-
Acibadem UniversityCompletedPatient Satisfaction | Patient Relations, NurseTurkey
-
University Hospital, ToulouseCompletedSatisfaction, PatientFrance
-
University of AarhusAarhus University HospitalCompletedPatient Satisfaction | Patient-Centered CareDenmark
-
Dr Abdurrahman Yurtaslan Ankara Oncology Training...CompletedPatient Satisfaction | Bowel Preparation | Patient ExperienceTurkey